Waiting for cancer treatment is never easy, and new research suggests that these waits are getting longer for many people. In a large study of more than 2.7 million individuals with several types of cancer, including breast cancer, colon cancer, lung cancer, pancreatic cancer, gastric cancer, and esophageal cancer, the time between diagnosis and first treatment increased noticeably over the past decade. For anyone facing a new diagnosis, worrying about cancer treatment wait times is completely understandable, and the findings highlight why timing has become a growing concern.

The study focused on people diagnosed with stage I, stage II, and stage III disease and tracked how many days passed before their first treatment, which was usually surgery. Across all six cancers studied, the average time from diagnosis to treatment rose by at least 10 days between 2012 and 2023. That change may sound small at first glance, but when someone is living with the anxiety of a new cancer diagnosis, each extra day can feel very significant.

For breast cancer specifically, the average wait time went from 34 days in 2012 to 45 days in 2023. That is an increase of more than a week. Colon cancer wait times grew from 20 days to 31 days. For lung cancer, the average wait climbed from 41 to 53 days. Pancreatic cancer patients saw waits grow from 23 to 32 days, gastric cancer from 35 to 49 days, and esophageal cancer from 38 to 48 days. Across very different cancer types, the same pattern emerged: people were waiting longer before their first treatment began.

The researchers did not only look at average wait times. They also examined how many people experienced what they described as a prolonged delay, meaning 30 or more days between diagnosis and first treatment, and an extreme delay, meaning 60 or more days. Here, too, the trend was troubling. Among people with breast cancer, the percentage who waited at least 30 days increased from 59% in the years 2012 through 2015 to 78% in 2022 through 2023. That suggests that delays have become the norm rather than the exception for many individuals starting breast cancer treatment.

The shift in extreme delays is also striking. Between 2012 and 2015, 19% of people with breast cancer waited 60 days or more before beginning treatment. By 2022 through 2023, that number had climbed to 32%. Nearly one in three people with breast cancer in the later period experienced what the study classified as an extreme delay. I found this detail striking because it captures not just a modest increase, but a significant jump in the share of people waiting two months or longer after hearing the word “cancer.”

The study also explored which groups of people were more likely to face these longer wait times. Several social and structural factors were associated with greater delays. Being in the lowest income bracket was linked with longer waits, as was having Medicaid coverage or having no health insurance at all. Black patients were also more likely to experience delays. These findings reflect ongoing concerns about health equity and how a person’s resources and background can shape their access to timely cancer care.

Geography appeared to play a role as well. People who had to travel longer distances for cancer treatment were more likely to face extended waits. On the surface, this may make intuitive sense, since longer travel often means more complex scheduling and coordination. However, it also suggests that where someone lives, and how close they are to a treatment center, may influence when their care can realistically begin.

Interestingly, the study reported that having treatment at an academic or high-volume cancer center was also linked with longer wait times. These centers typically see large numbers of patients and often offer specialized care, clinical trials, and multidisciplinary teams. While they can provide advanced expertise, the increased demand for services may come with more limited availability of operating rooms and appointment slots. The research did not claim that these centers offer worse care, only that patients treated there tended to wait longer before their first treatment was carried out.

The researchers pointed out that their findings are consistent with earlier studies that have documented inequalities in access to cancer care. In particular, delays in surgery may contribute to differences in outcomes between groups. While this study did not directly measure survival or recurrence, the authors suggest that longer waits can be one of several factors that feed into disparities that have already been observed in cancer results.

At the same time, the researchers were careful to note an important limitation. The data they used came from the National Cancer Database, which does not capture the reasons behind treatment delays. That means not every delay is necessarily a system failure or barrier. In some cases, people may choose to postpone their initial surgery for personal reasons. They may want to seek a second opinion, gather more information about their diagnosis, or explore different treatment options before deciding how to proceed. Others may schedule surgery around significant life events such as a planned vacation, family gathering, or major milestone, preferring to maintain some control and normalcy during a stressful time.

This nuance matters, because it reminds readers that longer time to treatment is not always a sign of poor care or neglect. Some delays are driven by patient preference, personal circumstances, or shared decision making with a care team. Still, when so many people are waiting longer across multiple cancer types, it suggests that broader structural issues are involved, and that access to timely surgery and treatment is an important area for improvement.

When to Speak Up

For individuals currently navigating a cancer diagnosis, it can be difficult to know what is an acceptable wait and when to speak up. The experts quoted in the source material emphasize that if someone is worried about how long it is taking to start treatment, they should consider asking their cancer center for help from a nurse navigator or case manager. These professionals are familiar with the many moving parts inside a busy cancer program, from surgeons and oncologists to imaging, lab work, and operating room schedules. They can coordinate appointments, streamline referrals, and often spot opportunities to move things along more quickly.

Advocating for oneself in the middle of a cancer diagnosis can feel overwhelming, yet knowing that there are specific roles designed to help manage the process may provide some practical reassurance. Whether someone is waiting for breast cancer surgery or another type of cancer treatment, engaging a navigator or case manager can be one concrete way to get clearer information and potentially reduce avoidable delays.

Ultimately, the study’s findings highlight a complex reality. Average wait times for the first cancer treatment have increased across several major cancer types, and prolonged or extreme delays have become more common, especially in breast cancer care. These delays do not fall evenly across all patients, but instead intersect with factors such as income, insurance status, race, travel distance, and treatment setting. While some delays reflect personal choice or thoughtful planning, others likely stem from systemic challenges that health systems and policymakers will need to address.

For now, people facing a new diagnosis can take away a few key ideas. Longer waits are increasingly common, they may not always signal that something is wrong, and there are professionals within cancer centers whose focus is helping patients move through the system as smoothly as possible. Asking questions about timing, seeking clarity about next steps, and requesting support from a nurse navigator or case manager can all be reasonable and empowering responses when the days between diagnosis and treatment start to stretch.

Read more at https://www.breastcancer.org/news/longer-wait-times-for-breast-cancer-treatment